期刊文献+

miRNA-206在胃间质瘤组织中的表达及其临床意义 被引量:4

Clinical significance of miRNA-206 expression in gastric stromal tumor
原文传递
导出
摘要 目的探讨miRNA-206在胃间质瘤中的表达及意义。方法收集胃间质瘤治疗后的切除标本,采用qRT-PCR方法检测53例胃间质瘤及对应正常胃组织中miRNA-206的表达,并分析其与临床病理因素的关系。结果胃间质瘤组织中miRNA-206表达显著低于对应正常胃组织(P<0.05),且核分裂数≥5/50 HPF病例的miRNA-206表达显著低于核分裂数<5/50 HPF病例的miRNA-206表达(P<0.05),Fletcher分级中/高危病例的miRNA-206表达显著低于极低/低危分级病例的miRNA-206表达(P<0.05)。结论 miRNA-206在胃间质瘤组织中表达下调,且与核分裂像及Fletcher分级密切相关,提示其在胃间质瘤的发生发展过程中发挥重要作用。 Objective To evaluate the expression and significance of miRNA-206 in the development of gastric stromal tumor. Methods Fifty-three cases of the surgical specimens of gastric stromal tumor were collected. miRNA-206 levels in matched pairs of gastric stromal tumor and normal adjacent tissue samples were examined using qRT-PCR; the relationship between miRNA-206 levels and clinical characteristics were investigated. Results Expression of miRNA-206 was significantly lower in tumor than that in adjacent normal tissues( P〈0. 05). Expression of miRNA-206 in cases with mitotic count≥5 /50 HPF was significantly lower than that with mitotic count 5 /50HPF( P〈0. 05). By Fletcher risk stratification system,expression of miRNA-206 in intermediate / high-risk cases was significantly lower than that in very low/ lowrisk cases( P〈0. 05). Conclusion In gastric stromal tumor,miRNA-206 expression is significantly down-regulated,and is closely associated with mitotic counts and Fletcher risk stratification system,which suggests that miRNA-206 play an important role in the process of development of gastric stromal tumor.
出处 《山东大学学报(医学版)》 CAS 北大核心 2015年第12期67-70,共4页 Journal of Shandong University:Health Sciences
基金 国家自然科学基金(81472685)
关键词 胃间质肿瘤 miRNA-206 临床特征 核分裂像 Fletcher分级 Gastric stromal tumors miRNA-206 Clinical characteristics M itotic count Fletcher risk stratification
  • 相关文献

参考文献25

  • 1Shinomura Y, Kinoshita K, Tsutsui S, et al. Pathophysi- ology, diagnosis, and treatment of gastrointestinal stromal tumors[J]. J Gastroenterol, 2005,40(8) : 775-780.
  • 2Corless CL, Fletcher JA, Heinrich MC. Biology of gas- trointestinal stromal tumors [ J ]. J Clin Oncol, 2004, 22(18) : 3813-3825.
  • 3He L, Harmon GJ. MicroRNAs: small RNAs with a big role in gene regulation [J]. Nat Rev Genet, 2004, 5 (7) : 522-531.
  • 4Croce CM. Causes and consequences of microRNA dys- regulation in cancer[J]. Nat Rev Genet, 2009, 10(10) : 704-714.
  • 5Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach[J]. Int J Surg Pathol, 2002, 10(2) : 81-89.
  • 6Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis [J]. Arch Pathol Lab Med, 2006, 130(10): 1466-1478.
  • 7Lennartsson J, Ronnstrand L. The stem cell factor recep- tor/c-Kit as a drug target in cancer[J]. Curt Cancer Drug Targets, 2006, 6(1): 65-75.
  • 8Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach[ J]. Hum Pathol, 2002, 33(5) : 459-465.
  • 9Subramanian S, Lui WO, Lee CH, et al. MicroRNA ex- pression signature of human sarcomas [J ]. Oncogene, 2008, 27(14): 2015-2026.
  • 10Jovanovic M, Hengartner MO. miRNAs and apoptosis: RNAs to die for[J]. Oncogene, 2006, 25(46) : 6176- 6187.

二级参考文献8

  • 1李金花,谢海龙.MicroRNA与肿瘤[J].国际病理科学与临床杂志,2007,27(1):11-14. 被引量:2
  • 2Mucciarini C,Rossi G,Bertolini F,et al.Incidence and clinicopathologic features of gastrointestinal stromal tumors:a population-based study.BMC Cancer,2007,7:230.
  • 3Demetri GD,Benjamin RS,Blanke CD,et al.NCCN task force report:optimal management of patients with gastrointestinal stromal tumor (GIST) update of the NCCN clinical practice guidelines.J Natl Compr Canc Netw,2007,5 Suppl 2:S1-29.
  • 4Volinia S,Calin GA,Liu CG,et al.A microRNA expression signature of human solid tumors defines cancer gene targets.Proc Natl Acad Sci USA,2006,103:2257-2261.
  • 5Slaby O,Svoboda M,Fabian P,et al.Altered expression of miR-21,miR-31,miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer.Oncology,2007,72:397-402.
  • 6Katada T,Ishiguro H,Kuwabara Y,et al.microRNAexpression profile in undifferentiated gastric cancer.Int J Oncol,2009,34:537-542.
  • 7Wang CJ,Zhou ZG,Wang L,et al.Clinicopathological significance of microRNA-31,-143 and -145 expression in colorectal cancer.Dis Markers,2009,26:27-34.
  • 8Haller F,von Heydebreck A,Zhang JD,et al.Localization-and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs),with a cluster of co-expressed miRNAs located at 14q32.31.J Pathol,2010,220:71-86.

共引文献4

同被引文献32

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部